Furthermore, the transwell assay was performed to evaluate cell migration, and we validated that microRNA-338-5p inhibited NPC cell migration through targeting WNT2B (P < 0.05, Figures 5F, G). This evidence concerns the gene WNT2B and nasopharyngeal carcinoma.